Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USA
about
Immunopharmacotherapy of non-infectious uveitis: where do we stand?Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-upDirect and indirect resource use, healthcare costs and work force absence in patients with non-infectious intermediate, posterior or panuveitis.MC5r and A2Ar Deficiencies During Experimental Autoimmune Uveitis Identifies Distinct T cell Polarization Programs and a Biphasic Regulatory ResponseThe Spectrum of Uveitis in Southern Vietnam.
P2860
Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USA
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Healthcare costs and utilizati ...... -infectious uveitis in the USA
@en
Healthcare costs and utilizati ...... infectious uveitis in the USA.
@nl
type
label
Healthcare costs and utilizati ...... -infectious uveitis in the USA
@en
Healthcare costs and utilizati ...... infectious uveitis in the USA.
@nl
prefLabel
Healthcare costs and utilizati ...... -infectious uveitis in the USA
@en
Healthcare costs and utilizati ...... infectious uveitis in the USA.
@nl
P2093
P2860
P356
P1476
Healthcare costs and utilizati ...... -infectious uveitis in the USA
@en
P2093
David S Chu
Matthew R Davis
Mei Sheng Duh
Rachael A Sorg
Scott J Johnson
Usha G Mallya
P2860
P2888
P356
10.1186/1869-5760-3-64
P577
2013-11-06T00:00:00Z
P5875
P6179
1008021817